Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HIV Treatment in Developing Countries.

Mason1, Katzenstein

  • 1Department of Medical Laboratory Sciences, University of Zimbabwe, PO Box CY1753, Causeway, Harare, Zimbabwe.

Current Infectious Disease Reports
|November 30, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Wound of the Intestine-Recovery.

Chicago medical examiner·2023
Same author

Case of Vicarious Menstruation.

Atlanta medical and surgical journal·2022
Same author

An idiopathic facial dermatitis of Persian cats.

Veterinary dermatology·2021
Same author

Speeding publication.

Veterinary dermatology·2021
Same author

The use of compound 48/80 as a positive control in equine intradermal allergy testing.

Veterinary dermatology·2021
Same author

Follicular thyroid cancer: an update.

Current surgery·2000
Same journal

Chagas Disease: An Opportunistic Infection in AIDS.

Current infectious disease reports·2026
Same journal

Area-based Deprivation Indices and Healthcare-Associated Infections: A Narrative Review of Evidence.

Current infectious disease reports·2025
Same journal

Next Steps: Studying Diabetic Foot Infections with Next-Generation Molecular Assays.

Current infectious disease reports·2024
Same journal

To Tweet or Not to Tweet-a Review of the Viral Power of Twitter for Infectious Diseases.

Current infectious disease reports·2024
Same journal

Web alert.

Current infectious disease reports·2024
Same journal

Bacterial Vaginosis in Postmenopausal Women.

Current infectious disease reports·2023
See all related articles

HIV treatment in developing nations must prioritize cost-effective prevention and opportunistic infection management due to economic constraints. Strategies to combat antimicrobial resistance and targeted antiretroviral prophylaxis are crucial for public health.

Area of Science:

  • Global Health
  • Infectious Diseases
  • Public Health Policy

Background:

  • Advanced HIV diagnostics and treatments are impactful in wealthy nations but inaccessible in developing countries where over 95% of infections occur.
  • Economic limitations in developing nations necessitate a shift in HIV management towards affordable prevention and opportunistic infection (OI) treatment.

Purpose of the Study:

  • To outline essential HIV management strategies for developing countries, focusing on cost-effective interventions.
  • To highlight key opportunistic infections and the importance of antimicrobial resistance surveillance.

Main Methods:

  • Focus on prevention and treatment of opportunistic infections like tuberculosis, Pneumocystis carinii pneumonia (PCP), and pneumococcal pneumonia using available, inexpensive antimicrobial agents.

Related Experiment Videos

  • Review of current strategies for preventing mother-to-child HIV transmission using antiretroviral agents.
  • Consideration of post-exposure prophylaxis for high-risk groups as a potentially affordable intervention.

    • Main Results:

    • Tuberculosis, PCP, and pneumococcal pneumonia are primary targets for OI management in developing countries.
    • Antimicrobial resistance in mycobacteria and pneumococci poses a significant threat, requiring high-priority control strategies.
    • Antiretroviral agents are currently limited to preventing mother-to-child transmission, with notable success, but widespread use is economically unfeasible.

    Conclusions:

    • HIV care in developing countries must prioritize accessible prevention and OI management, emphasizing cost-effective antimicrobial therapies.
    • Combating antimicrobial resistance is critical for effective HIV/AIDS treatment and public health in resource-limited settings.
    • Targeted antiretroviral strategies, such as post-exposure prophylaxis for high-risk populations, may offer a viable and affordable approach to HIV control.